Idp4 Oct 2017 06:47
Innovaderma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of anti-ageing, body contouring, hair loss treatment, and wellbeing products for men and women in Australia, New Zealand, England, the Philippines, Hong Kong, South Korea, and the United Arab Emirates. Formed in 2014, and now run by , the company size now stands at 24 people and with the stock’s market cap sitting at GBP £31.50M, it comes under the small-cap category.
IDP’s forecasted bottom line growth is an exceptional 320.91%, driven by the underlying 124.65% sales growth over the next few years. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 33.30%. IDP’s impressive outlook on all aspects makes it a worthy company to spend more time to understand